UMB Bank N A MO reduced its position in shares of Cigna Corporation (NYSE:CI) by 0.0% during the second quarter, Holdings Channel reports. The firm owned 10,820 shares of the health services provider’s stock after selling 2 shares during the period. UMB Bank N A MO’s holdings in Cigna Corporation were worth $1,811,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Profund Advisors LLC raised its stake in shares of Cigna Corporation by 8.3% in the first quarter. Profund Advisors LLC now owns 10,359 shares of the health services provider’s stock worth $1,517,000 after buying an additional 795 shares in the last quarter. First Manhattan Co. raised its position in Cigna Corporation by 4.5% in the first quarter. First Manhattan Co. now owns 9,910 shares of the health services provider’s stock worth $1,291,000 after buying an additional 424 shares during the period. Mn Services Vermogensbeheer B.V. raised its position in Cigna Corporation by 3.1% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 6,847 shares of the health services provider’s stock worth $938,000 after buying an additional 205 shares during the period. Candriam Luxembourg S.C.A. raised its position in Cigna Corporation by 20.3% in the first quarter. Candriam Luxembourg S.C.A. now owns 15,839 shares of the health services provider’s stock worth $2,320,000 after buying an additional 2,672 shares during the period. Finally, State of Alaska Department of Revenue bought a new position in Cigna Corporation during the first quarter worth $689,000. Institutional investors and hedge funds own 86.91% of the company’s stock.

Cigna Corporation (NYSE:CI) opened at 174.38 on Friday. Cigna Corporation has a 12-month low of $115.03 and a 12-month high of $178.57. The stock has a market cap of $43.91 billion, a P/E ratio of 20.12 and a beta of 0.46. The stock has a 50 day moving average price of $172.22 and a 200-day moving average price of $159.17.

Cigna Corporation (NYSE:CI) last announced its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 7.46%. The business had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. During the same period in the previous year, the company earned $1.98 earnings per share. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, equities analysts expect that Cigna Corporation will post $10.02 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This report was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.watchlistnews.com/cigna-corporation-nyseci-position-lowered-by-umb-bank-n-a-mo/1478711.html.

A number of equities analysts have weighed in on CI shares. Jefferies Group LLC reissued a “buy” rating and set a $178.00 price objective (up previously from $172.00) on shares of Cigna Corporation in a research note on Sunday, April 23rd. Zacks Investment Research raised Cigna Corporation from a “hold” rating to a “buy” rating and set a $175.00 price objective on the stock in a research note on Tuesday, April 25th. Stifel Nicolaus boosted their price objective on Cigna Corporation from $170.00 to $175.00 and gave the stock a “buy” rating in a research note on Friday, May 5th. Deutsche Bank AG boosted their price objective on Cigna Corporation from $172.00 to $175.00 and gave the stock a “buy” rating in a research note on Wednesday, May 10th. Finally, Royal Bank Of Canada boosted their price objective on Cigna Corporation from $172.00 to $177.00 and gave the stock an “outperform” rating in a research note on Monday, May 15th. Three investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $180.06.

In related news, insider Michael W. Triplett sold 1,439 shares of the business’s stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $166.89, for a total value of $240,154.71. Following the completion of the sale, the insider now directly owns 26,199 shares of the company’s stock, valued at $4,372,351.11. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Nicole S. Jones sold 20,312 shares of the business’s stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $160.04, for a total value of $3,250,732.48. Following the completion of the sale, the executive vice president now directly owns 44,737 shares of the company’s stock, valued at $7,159,709.48. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 261,539 shares of company stock worth $44,527,348. Corporate insiders own 1.30% of the company’s stock.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.